3-04-2025, 18:16

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

Notified -
Globe Newswire3-04-2025, 18:16
26-09-2024, 23:34

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
Globe Newswire26-09-2024, 23:34